Authors
Latest:
FSP Partnership: A Foundation for Innovation and Patient-Guided DevelopmentLiz Rogers, VP and Head of Global Site and Study Operations at Pfizer, discusses Pfizer's partnership with Parexel and transition to a functional service provider (FSP) model.
Latest:
Outsourcing Strategies and Practices to Improve Efficiency and PerformanceDemand for outsourced services to provide clinical development capacity and expertise has grown substantially over the last 10 years.
Latest:
Outsourcing Strategies and Practices to Improve Efficiency and PerformanceDemand for outsourced services to provide clinical development capacity and expertise has grown substantially over the last 10 years.
Latest:
Improving Minority Recruitment in Clinical TrialsPromising new approaches to optimize data and outcomes.
Latest:
Focus on the Patient: The Digital Evolution of IRTCenduit has benefited greatly from the relationship we have with our parent companies, from Quintiles’ clinical development experience to Thermo Fisher Scientific’s clinical supply chain know-how.
Latest:
Death Waivers an Incomplete Picture of Drug SafetyExamining the practical significance of reporting patient deaths due to main disease progression.
Latest:
Death Waivers an Incomplete Picture of Drug SafetyExamining the practical significance of reporting patient deaths due to main disease progression.
Latest:
Interexpert Agreement on Adverse Events’ EvaluationStudy measures the differing judgment levels between clinical investigators and drug safety experts.
Latest:
Death Waivers an Incomplete Picture of Drug SafetyExamining the practical significance of reporting patient deaths due to main disease progression.
Latest:
Eyes Play a Focal Role in ResearchTwo unique techniques help characterize pharmacodynamic drug effects in healthy subjects.
Latest:
In Pursuit of EnlightenmentKnowledge is power, but power is of no value if you don't exercise it.
Latest:
Human Gene Transfer Studies: What Clinicians Should KnowThis experimental technique is being studied to see whether it could treat certain health problems.
Latest:
Human Gene Transfer Studies: What Clinicians Should KnowThis experimental technique is being studied to see whether it could treat certain health problems.
Latest:
How Technology Can Help ClinOps Leaders Build a Quality CultureClinical trials are time sensitive, costly endeavors with high-risk and high-expectations at every juncture.
Latest:
A Look at Independent E-Signatures to Limit the Paper Burden in Clinical TrialsAcross the pharmaceutical industry, advances in digital technology play a key role in driving the efficiency of the drug development process, particularly for clinical trials.
Latest:
Barriers to Trial Recruitment and Possible SolutionsSurvey takes deep dive into enrollment hurdles, aims to inform future recommendations for improvement.
Latest:
Models of Engagement: Patients as Partners in Clinical ResearchExploring three distinct patient partnership models to help researchers assess which methods of engagement could work best for their clinical programs.
Latest:
Barriers to Trial Recruitment and Possible SolutionsSurvey takes deep dive into enrollment hurdles, aims to inform future recommendations for improvement.
Latest:
Barriers to Trial Recruitment and Possible SolutionsSurvey takes deep dive into enrollment hurdles, aims to inform future recommendations for improvement.
Latest:
Barriers to Trial Recruitment and Possible SolutionsSurvey takes deep dive into enrollment hurdles, aims to inform future recommendations for improvement.
Latest:
Designing Alzheimer’s Disease Clinical Trials For SuccessAlzheimer’s disease (AD) is and will remain one of the most unyielding public health crises of the 21st century. Aging global populations translate to a constantly growing prevalence of a disease with no cure and an immense cost of care. In the United States alone, recent estimates1 suggest that 28 million people will develop AD by midcentury. Approximately 25% of the annual Medicare budget will be spent treating the disease – a projected $330B in 2040 – with hundreds of billions more in indirect costs.
Latest:
Site Challenges in Eastern EuropeSurvey sheds light on the regional-specific risks of managing clinical trial sites in Eastern Europe.
Latest:
Site Challenges in Eastern EuropeSurvey sheds light on the regional-specific risks of managing clinical trial sites in Eastern Europe.
Latest:
Site Challenges in Eastern EuropeSurvey sheds light on the regional-specific risks of managing clinical trial sites in Eastern Europe.
Latest:
Is a Bigger CRO Better?Much of the growth that has taken place in the top tier of CROs in recent years has been in the acquisition of some of the smaller, more innovative companies, rather than an increase in the number of compounds under study.
